Health Outcomes and Policy

In large national registries and datasets, we have defined both methodologic best practices for rigorous investigation and identified adherence to evidenced-based cardiovascular care

Methodological Best Practices


Clinician Trends in Prescribing Direct Oral Anticoagulants for US Medicare Beneficiaries


ICD10Checklist.png

Transition to the ICD-10 in the United States

An Emerging Data Chasm


NonadherenceNIS.png

Adherence to Methodological Standards in Research Using the National Inpatient Sample


AdmCode.png

Administrative Codes for Capturing In-Hospital Cardiac Arrest

Acute Cardiovascular Care

We have evaluated national patterns of care and outcomes of patients hospitalized with cardiovascular conditions, and the concordance of care practices with clinical guidelines


MultivesselPCI.png

Revascularization Practices and Outcomes in Patients With Multivessel Coronary Artery Disease Who Presented With Acute Myocardial Infarction and Cardiogenic Shock in the US, 2009-2018


MIStratified.png

Temporal Trends in Heart Failure Incidence Among Medicare Beneficiaries Across Risk Factor Strata, 2011 to 2016


ValvReplacementPerformance.png

Role of Hospital Volumes in Identifying Low-Performing and High-Performing Aortic and Mitral Valve Surgical Centers in the United States


pvad.png

Trends in the Use of Percutaneous Ventricular Assist Devices:

Analysis of National Inpatient Sample Data, 2007 Through 2012

Cardiac Arrest

We have defined a series of quality measures for the care of patients with in-hospital and out-of-hospital cardiac arrest


Time in therapeutic range for targeted temperature management and outcomes following out-of-hospital cardiac arrest


CardArrestChildren.png

Pulselessness After Initiation of Cardiopulmonary Resuscitation for Bradycardia in Hospitalized Children.


Award.jpg

Association Between Hospital Recognition for Resuscitation Guideline Adherence and Rates of Survival for In-Hospital Cardiac Arrest


TTM.jpg

Hospital Variation in the Utilization and Implementation of Targeted Temperature Management in Out-of-Hospital Cardiac Arrest


Epi paper.jpg

Hospital Variation in Time to Epinephrine for Nonshockable In-Hospital Cardiac Arrest

Our work focuses on a rigorous evaluation of health policies and their association with cardiovascular health and outcomes

Financial Toxicity from Cardiovascular Care

We have uncovered a large burden of financial toxicity from healthcare among patients with cardiovascular disease, a function of both their emergency and acute care needs as well as out-of-pocket expenses on health insurance and health maintenance


Out‐of‐Pocket Annual Health Expenditures and Financial Toxicity From Healthcare Costs in Patients With Heart Failure in the United States


Financial Toxicity in Atherosclerotic Cardiovascular Disease in the United States: Current State and Future Directions


Cost-Related Medication Nonadherence in Adults With Atherosclerotic Cardiovascular Disease in the United States, 2013 to 2017.


Association of Out-of-Pocket Annual Health Expenditures With Financial Hardship in Low-Income Adults With Atherosclerotic Cardiovascular Disease in the United States


Burden of Catastrophic Health Expenditures for Acute Myocardial Infarction and Stroke Among Uninsured in the United States

Hospital Readmissions

In a series of investigations, we rigorously evaluated the effects of the Hospital Readmission Reduction Program on readmissions, mortality, and post-acute care.


Post-discharge acute care and outcomes following readmission reduction initiatives: national retrospective cohort study of Medicare beneficiaries in the United States


Evaluation of 30-Day Hospital Readmission and Mortality Rates Using Regression-Discontinuity Framework


Association of the Hospital Readmissions Reduction Program With Mortality During and After Hospitalization for Acute Myocardial Infarction, Heart Failure, and Pneumonia


Burden of Catastrophic Health Expenditures for Acute Myocardial Infarction and Stroke Among Uninsured in the United States

Therapeutic evaluation

We have evaluated both the effectiveness and risk-stratification tools used to define the need for therapy in different populations


Performance of the Pooled Cohort Equations to Estimate Atherosclerotic Cardiovascular Disease Risk by Body Mass Index


Impact of 2017 ACC/AHA guidelines on prevalence of hypertension and eligibility for antihypertensive treatment in United States and China: nationally representative cross sectional study